Mesenchymal Stem Cells Delivery in Individuals with Different Pathologies: Multimodal Tracking, Safety and Future Applications

Mesenchymal Stem Cells Delivery in Individuals with Different Pathologies: Multimodal Tracking, Safety and Future Applications

Due to their ease of isolation and their properties, mesenchymal stem cells (MSCs) have been widely investigated. MSCs have been proved capable of migration towards areas of inflammation, including tumors. Therefore, they have been suggested as vectors to carry therapies, specifically to neoplasias....

Full description

Bibliographic Details
Main Authors:	Carolina Belmar-López, Georges Vassaux, Ana Medel-Martinez, Jerome Burnet, Miguel Quintanilla, Santiago Ramón y Cajal, Javier Hernandez-Losa, Antonio De la Vieja, Pilar Martin-Duque
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	International Journal of Molecular Sciences
Subjects:	mesenchymal stem cells sodium/iodide symporter (NIS) transdifferentiation therapy Imaging PET SPECT
Online Access:	https://www.mdpi.com/1422-0067/23/3/1682

Similar Items

Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice
by: Carolin Kitzberger, et al.
Published: (2023-09-01)

Selective sodium iodide symporter (NIS) gene therapy of glioblastoma mediated by EGFR-targeted lipopolyplexes
by: Rebekka Spellerberg, et al.
Published: (2021-12-01)

Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
by: Antonio De la Vieja, et al.
Published: (2021-02-01)

Progress in gene therapy for prostate cancer
by: Kamran Ali Ahmed, et al.
Published: (2012-11-01)

Tumor microenvironment affects exogenous sodium/iodide symporter expression
by: Fabio Castillo-Rivera, et al.
Published: (2021-01-01)

Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
by: Nan-Fang Luo, et al.
Published: (2024-03-01)

Research Progress on Pathogenic Factors of Breast Cancer Combined with Thyroid Cancer
by: JIANG Huan, et al.
Published: (2021-05-01)

Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
by: Rebekka Spellerberg, et al.
Published: (2022-12-01)

A novel strategy of transferring NIS protein to cells using extracellular vesicles leads to increase in iodine uptake and cytotoxicity
by: Son SH, et al.
Published: (2019-03-01)

High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
by: Dmitry Soloviev, et al.
Published: (2022-12-01)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
by: Jierui Liu, et al.
Published: (2019-09-01)

Transcription Factor CREB3L1 Regulates the Expression of the Sodium/Iodide Symporter (NIS) in Rat Thyroid Follicular Cells
by: Pablo Di Giusto, et al.
Published: (2022-04-01)

In Vivo Myoblasts Tracking Using the Sodium Iodide Symporter Gene Expression in Dogs
by: Isabel Punzón, et al.
Published: (2020-06-01)

Evaluation of the diphenyl herbicide, oxyfluorfen, for effects on thyroid hormones in the juvenile rat
by: T.E. Stoker, et al.
Published: (2024-01-01)

Seaweed and Iodine Intakes and rs77277498 in Relation to Thyroid Cancer
by: Tung Hoang, et al.
Published: (2022-06-01)

Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjects
by: Huailei Jiang, et al.
Published: (2017-10-01)

Exogenous Melatonin Protects against Oxidative Damage to Membrane Lipids Caused by Some Sodium/Iodide Symporter Inhibitors in the Thyroid
by: Aleksandra K. Gładysz, et al.
Published: (2023-08-01)

Radioactive Iodine Therapy and Glucose Tolerance
by: Roghaieh Samadi, et al.
Published: (2017-04-01)

Prevalence of Thyroid Disorders in and around Nalgonda District, Telangana, India: A Cross-sectional Study
by: Pullaiah Akinepalli, et al.
Published: (2023-01-01)

Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
by: Hutzen Brian, et al.
Published: (2012-11-01)

Targeted Next-Generation Sequencing of Congenital Hypothyroidism-Causative Genes Reveals Unexpected Thyroglobulin Gene Variants in Patients with Iodide Transport Defect
by: Carlos Eduardo Bernal Barquero, et al.
Published: (2022-08-01)

The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
by: Carolin Kitzberger, et al.
Published: (2022-05-01)

Tracking dendritic cell migration into lymph nodes by using a novel PET probe 18F-tetrafluoroborate for sodium/iodide symporter
by: Sang Bong Lee, et al.
Published: (2017-04-01)

Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer
by: Yoon Ju Choi, et al.
Published: (2021-01-01)

Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model
by: Kensuke Suzuki, et al.
Published: (2022-08-01)

Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene
by: Seul-Gi Oh, et al.
Published: (2023-09-01)

Analysis of the T354P mutation of the sodium/iodide cotransporter gene in children with congenital hypothyroidism due to dyshormonogenesis
by: Hajar Miranzadeh-Mahabadi, et al.
Published: (2016-01-01)

Spatiotemporal quantitative microRNA-155 imaging reports immune-mediated changes in a triple-negative breast cancer model
by: Elena Skourti, et al.
Published: (2023-06-01)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
by: Ji Min Oh, et al.
Published: (2022-03-01)

SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway
by: Jiancang Ma, et al.
Published: (2023-09-01)

Study on the Iodine 125 Uptake of H460 Lung Cancer Cell Line by Co-transfection with the Human Sodium/Iodide Symporter and the Human Thyroperoxidase
by: Wei LI, et al.
Published: (2010-06-01)

Original paper<br>Correlation between level of sodium/iodide symporter expression in tissue sections and some clinical parameters in patients with nodular goiter
by: Anhelli Syrenicz, et al.
Published: (2006-12-01)

Silent but Not Harmless: A Synonymous SLC5A5 Gene Variant Leading to Dyshormonogenic Congenital Hypothyroidism
by: Romina Celeste Geysels, et al.
Published: (2022-05-01)

Propensity Score-Matched Analysis to Identify Pathways Associated with Loss of Sodium Iodide Symporter in Papillary Thyroid Cancer
by: Fang Lee, et al.
Published: (2022-03-01)

Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer
by: Jing Zhang, et al.
Published: (2022-09-01)

Relationship of In Vitro Toxicity of Technetium-99m to Subcellular Localisation and Absorbed Dose
by: Ines M. Costa, et al.
Published: (2021-12-01)

Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter
by: Xiao-Feng Gao, et al.
Published: (2014-02-01)

Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
by: June-Key Chung, et al.
Published: (2014-09-01)

Cancer gene therapy: Prospects of using human sodium iodide symporter gene in non-thyroidal cancer
by: Shruti Dutta, et al.
Published: (2015-01-01)

Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion
by: Matthew Glen Robertson, et al.
Published: (2021-03-01)